| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.002 |